← Evidence map

ReviewJournal of clinical hypertension (Greenwich, Conn.)2023

Aprocitentan: A new development of resistant hypertension.

Yao Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37334561